| Filed On | Filing |
|---|---|
| 17 Aug 2018 |
Form 3/A: Oltmans Curtis Gale, General Counsel
Holds 0 shares of No securities are beneficially owned |
| 07 Aug 2014 | Form 3/A: Array Biopharma Inc, 10% owner · Loxo Oncology, Inc. |
Loading...
